Volume | 18,983 |
|
|||||
News | - | ||||||
Day High | 24.49 | Low High |
|||||
Day Low | 24.095 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
PTC Therapeutics Inc | PTCT | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
24.42 | 24.095 | 24.49 | 25.21 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
267 | 18,983 | $ 24.30 | $ 461,194 | - | 17.53 - 59.84 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
09:42:49 | 48 | $ 24.34 | USD |
PTC Therapeutics Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
1.87B | 76.61M | - | 1.07B | -626.6M | -8.18 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
PTC Therapeutics News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical PTCT Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 25.13 | 26.49 | 23.995 | 25.31 | 1,342,932 | -0.77 | -3.06% |
1 Month | 29.48 | 29.83 | 23.995 | 26.46 | 850,268 | -5.12 | -17.37% |
3 Months | 26.24 | 32.905 | 23.58 | 27.64 | 862,708 | -1.88 | -7.16% |
6 Months | 22.91 | 32.905 | 17.53 | 25.64 | 1,066,542 | 1.45 | 6.33% |
1 Year | 52.76 | 59.84 | 17.53 | 30.61 | 1,039,400 | -28.40 | -53.83% |
3 Years | 46.16 | 59.84 | 17.53 | 36.58 | 762,337 | -21.80 | -47.23% |
5 Years | 37.15 | 70.82 | 17.53 | 40.96 | 718,210 | -12.79 | -34.43% |
PTC Therapeutics Description
PTC Therapeutics Inc is a global biopharmaceutical company focused on the discovery, development, and commercialization of orally administered, small-molecule therapeutics. Its target area is RNA biology post-transcriptional control processes of the events occurring in a cell when a RNA messenger is copied from DNA during the transcription process. The discovered products address multiple therapeutic areas, including rare disorders, such as nonsense mutations in Duchenne muscular dystrophy and oncology. |